James W. Fawcett published the review « The extracellular matrix in plasticity and regeneration after CNS injury and neurodegenerative disease » in 2015, highlighting the key role of the chondroitin sulfate proteoglycans (CSPGs) of the extracellular matrix (ECM) in brain plasticity. CSPGs are present in the brain extracellular matrix and Read more…
The annual congress of Biology and Health PhD students from Lille (André Verbert day) took place at the Faculty of Medicine Thursday, September 10th. During this day, PhD students, in third year of thesis, had to present their works by talks, flash-talks or posters. Our PhD student Véronique De Conto Read more…
The founding congress of the french STCM (Société de Toxicologie Cellulaire et Moléculaire) will take place in Paris at the end of this week (13th-14th June, 2019). The theme of this meeting will be “Toxicology towards the 3rd dimension“. We are looking forward to attending this congress, and to becoming Read more…
The annual SCMC congress (Société Cerveau et Maladies Cérébrovasculaires – Brain and Cerebrovascular diseases Society) took place in Lille last week, in the Faculty of Medecine. The congress was organized in three sessions. The first session was about cerebrovascular development and maturation. The conferences began with a lecture about blood-brain Read more…
Next week HCS Pharma will be present both at Forum Labo Paris (26th-28th March ) and at SCMC congress in Lille (28-29th March)! In Forum Labo we will have our own stand in the Lab’StartUp Village (stand G11), thanks to the organizers for selecting BIOMIMESYS® Brain for the fair! We Read more…
HCS Pharma is one of the winner of the Lab’StartUp village, organized by Forum Labo! As such, we have won a stand in the heart of the forum (March 26-28, 2019)… Thanks a lot to the committee for evaluating our application to this prize, and for selecting our new product Read more…
We are developing a new BIOMIMESYS® hydroscaffold for neuronal cells. First results are very promising because neurons grow and form neurites. Moreover cells lived longer than in monolayer culture. We are currently finalizing this new hydroscaffold to find the best conditions of 3D neuron culture, but BIOMIMESYS® Brain will be soon Read more…
The annual meeting of the Society for the Study of Blood Brain interface (SEISC) took place in Paris the 9th November 2018. All day long, recent studies adressing different BBB issues have been presented, including Blood-Brain Barrier (BBB) development, molecular control, and several pathological aspects. BBB development: The meeting started Read more…
HCS Pharma will be present to the annual congress of the Society of Study of Blood-Brain Interfaces (SEISC) at Collège de France on Friday, November 9th 2018. The congress will begin by a plenary lecture about the molecular control of neurovascular development, given by Isabelle Brunet (CIRB, Collège de France), Read more…
The annual congress of the SCMC (French Brain and Cerebrovascular Diseases Society) took place in Paris last week. The meeting began with a mini-symposium entitled “Nanoparticles and the brain”, during which the therapeutic potential of nanomedicine was addressed: three invited speakers discussed the use of nanoparticules to treat cancers (by Read more…
Following the Rare Disease Day, we would like to highlight the next international workshop of BRAINS FOR BRAIN (B4B) Foundation, which will take place in Frankfurt (Germany) between the 8th and the 10th of March. B4B aims at improving the understanding and treatment of rare genetic diseases affecting the young Read more…
11 presentations, dealing with the importance of the BBB in neurodegenerative diseases
RNA fluorescence in situ hybridization (FISH)
Ever wanted to see the activity of the neurons from a almost entire brain ?